Article: Association of Laboratory Parameters with Clinical Outcomes of SARS-CoV-2 Patients
| creativeworkseries.issn | 1999-6217 | |
| dc.contributor.author | Neupane, Mamata Sharma | |
| dc.contributor.author | Hassan, Hafizah Che | |
| dc.contributor.author | Uranw, Surendra Kumar | |
| dc.contributor.author | Mehta, Raj Kumar | |
| dc.date.accessioned | 2026-08-20T04:03:49Z | |
| dc.date.available | 2026-08-20T04:03:49Z | |
| dc.date.issued | 2026 | |
| dc.description | Mamata Sharma Neupane Lincoln University College, Malaysia Hafizah Che Hassan Lincoln University College, Malaysia https://orcid.org/0000-0001-7292-4315 Surendra Kumar Uranw B.P.Koirala Institute of Health Sciences, Nepal https://orcid.org/0000-0002-1471-8318 Raj Kumar Mehta Chitwan Medical College, Bharatpur, Nepal https://orcid.org/0000-0002-1241-8119 | |
| dc.description.abstract | Abstract: Background: The COVID-19 pandemic has imposed a significant burden on healthcare systems, particularly in resource-limited settings. Laboratory biomarkers may help predict disease outcomes and guide clinical decisions. However, there is limited evidence from Nepal regarding the prognostic value of these markers among hospitalized COVID-19 patients. Methods: A hospital-based observational study was conducted among 348 RT-PCR–confirmed COVID-19 patients admitted to the COVID ICUs and wards of a tertiary care hospital in Nepal between March 2022 and June 2023. Data on sociodemographic characteristics, haematological parameters, liver and inflammatory markers, urine microscopy, and SARS-CoV-2 molecular gene markers were collected prospectively. Clinical outcomes were categorized as survived or died. Descriptive statistics, chi-square tests, and binary logistic regression were used to analyse associations and identify predictors of mortality. Results: Out of the total 348 patients included in the study, 71 patients (20.4%) died, while 277 patients (79.6%) survived. Among 348 patients, significant associations with mortality were observed for lymphopenia (p = .001), neutrophilia (p < .001), elevated ALT (p < .001), elevated AST (p = .001), and positive D-dimer (p < .001). High viral load (Ct value ?20) for E, N, and ORF1ab ab genes was also significantly associated with mortality in univariate analysis. Logistic regression identified D-dimer positivity (OR = 0.027, p = .001) and elevated ALT (OR = 0.356, p = .016) as independent predictors of mortality. Conclusions: Laboratory parameters, especially lymphocyte count, D-dimer, and ALT levels, are valuable prognostic indicators of clinical outcomes in hospitalized COVID-19 patients. Integrating these markers into clinical assessment may enhance early risk stratification and resource allocation. Keywords: Biomarkers; C-Reactive protein; COVID-19; critical care; d-dimer. | |
| dc.identifier | https://doi.org/10.33314/jnhrc.v24i01.5358 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/7369 | |
| dc.language.iso | en_US | |
| dc.publisher | Nepal Health Research Council | |
| dc.subject | Biomarkers | |
| dc.subject | C-Reactive protein | |
| dc.subject | COVID-19 | |
| dc.subject | critical care | |
| dc.subject | d-dimer | |
| dc.title | Association of Laboratory Parameters with Clinical Outcomes of SARS-CoV-2 Patients | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 166 | |
| oaire.citation.startPage | 159 | |
| relation.isJournalIssueOfPublication | a1c63b20-6d6e-4473-9408-632d1b427f81 | |
| relation.isJournalIssueOfPublication.latestForDiscovery | a1c63b20-6d6e-4473-9408-632d1b427f81 | |
| relation.isJournalOfPublication | 40bd2739-8b19-447c-be60-723a1bdd1dcd |